Former Virginia-based Notal Vision chief executive officer, and Vero Beach resident, Quinton Oswald has been critical in leading different companies on notable projects around biotech, ocular monitoring band encapsulated cell technology. He has worked in different companies across three continents. Quinton Oswald participates in career-oriented events, summits, and reviewing presentations, like at the Ophthalmology Innovation Source (OIS).
Launched in 2009, the OIS aims to unite entrepreneurs, industry executives, clinical thought leaders, and start-up companies to exhibit and showcase therapies in ophthalmology to sort out unmet clinical needs. The platform offers a rich source of central informational platforms through the media, data resources, and events for the stakeholders in the industry to offer insights on subjects of interest and networking.
The entirety of the OIS seeks to empower innovative solutions to empower vision and health through the input of industry leaders in the trade and supportive communities. One of the ways to achieve this objective is through events like the retina innovation summit.
The summit brings together specialists, medical groups, medical devices, research, and design groups working in various ways connected to the retina for a round table presentation on the latest retina research, ailments diagnosis and treatment, and technology focusing on the retina. The key speakers at the summit come from biotechnology, pharmacologists, therapeutics, biosciences, and ophthalmology.
